MedTrace Logo

Dose of Hepatitis B Vaccines in Non/Low-response Populations

NCT01564134 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 537

Last updated 2013-07-10

No results posted yet for this study

Summary

An interventional study will be performed in subjects aged 1-65 years old to evaluate effects of different doses of hepatitis B vaccines in low or non-response population.

Conditions

  • Vaccination; Complications, Reaction, Serum

Interventions

BIOLOGICAL

hepatitis B vaccine

hepatitis B vaccine with 5ug,10ug,20ug,60ug HBsAg

Sponsors & Collaborators

  • Beijing Municipal Science & Technology Commission

    collaborator OTHER

  • Wu Jiang

    lead OTHER_GOV

Principal Investigators

  • jiang wu, Bachelor · Beijing Centers for Disease Control and Prevention

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2012-03-31
Completion
2012-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01564134 on ClinicalTrials.gov